COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement of Resolutions of the Second Extraordinary General Meeting of 2014 of Jilin Zixin Pharmaceutical Co., Ltd.

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2014-027

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement of Resolutions of the Second Extraordinary General Meeting of 2014

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

Special Note:

1. There was no increase, veto or change of the resolution during the general meeting of shareholders.

2. The shareholders' meeting was voted on the spot.

I. Meeting convening and attendance

(1) The convening of the meeting

1. Meeting notice:

The board of directors of Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”) disclosed the information in Securities Times, Shanghai Securities News, Securities Daily, China Securities Journal and the company on March 27, 2014. The website www.cninfo.com.cn on the website www.cninfo.com.cn announced the notice and consideration of the meeting of the extraordinary general meeting.

2. Meeting time: starting at 9:00 am on Friday, April 11, 2014

3. Equity registration date: April 8, 2014

4. Meeting place: Meeting room of No. 137, Dongtoudao Street, Nanguan District, Changchun City

5. Convener of the meeting: the board of directors of the company

6. Mode of the meeting: The extraordinary general meeting of shareholders will adopt an on-site voting method.

7. Legal compliance of the meeting: The 13th meeting of the fifth board of directors of the company reviewed and approved the “Proposal for Holding the Second Extraordinary General Meeting of 2014” and decided to convene the second extraordinary shareholders meeting of the company in 2014. The convening of the EGM is in compliance with relevant laws and regulations and the company's articles of association.

(II) Attendance at the meeting

1. A total of 2 shareholders and shareholder representatives attending the on-site meeting of the EGM, representing 282,436,292 shares with voting rights, accounting for 55.06% of the total number of shares of the company.

2. Some directors, supervisors and senior management personnel of the company attended the meeting; Wang Xiuhong and Qu Chengliang, lawyers of the Beijing Branch of Beijing Law Firm, attended the shareholders meeting to witness and issued legal opinions.

2. Review and voting of the proposal

The EGM will adopt on-site voting. The proposal shall be agreed by more than one-half (including) of the total number of shares with valid voting rights held by the shareholders attending the general meeting. The second motion was voted on by a cumulative vote. The meeting voted by ballot to pass the following motion:

1. The “Proposal on Nominating the Independent Directors of the Fifth Session of the Board of Directors” was reviewed and approved.

Voting: 282,436,292 shares, 100% of the total number of shares with valid voting rights at the meeting; 0 shares, 0% of the total number of shares with valid voting rights at the meeting; 0 shares abstained, accounting for 0% of the total number of shares with valid voting rights at the meeting .

2. The “Proposal on Nominating the Non-Independent Directors of the Fifth Session of the Board of Directors” was reviewed and approved.

2.01. Proposal for by-election of Zhang Zhongwei as a non-independent director of the fifth board of directors

Voting: The total number of votes won was 282,436,292 votes, accounting for 100% of the total number of shares held by shareholders of the meeting (based on the number of unaccumulated shares).

2.02. Proposal for by-election of Li Baozhi as a non-independent director of the fifth board of directors

Voting: The total number of votes won was 282,436,292 votes, accounting for 100% of the total number of shares held by shareholders of the meeting (based on the number of unaccumulated shares).

2.03. Proposal for by-election Zhong Yunxiang as a non-independent director of the fifth board of directors

Voting: The total number of votes won was 282,436,292 votes, accounting for 100% of the total number of shares held by shareholders of the meeting (based on the number of unaccumulated shares).

The company's board of directors stated that among the members of the fifth board of directors of the company, the number of directors who are concurrently senior executives of the company does not exceed one-half of the total number of directors of the company.

3. The “Proposal on Nominating the Fourth Board of Supervisors of the Board of Supervisors” was reviewed and approved.

Voting: 282,436,292 shares, 100% of the total number of shares with valid voting rights at the meeting; 0 shares, 0% of the total number of shares with valid voting rights at the meeting; 0 shares abstained, accounting for 0% of the total number of shares with valid voting rights at the meeting .

The company's board of supervisors stated that the number of supervisors who have served as directors or senior executives of the company in the past two years has not exceeded one-half of the total number of supervisors of the company; the number of supervisors nominated by a single shareholder has not exceeded one-half of the total number of supervisors of the company.

Third, the legal opinions issued by lawyers

Wang Xiuhong and Qu Chengliang, lawyers from the Beijing branch of Beijing Law Firm, attended the annual general meeting of shareholders and issued a legal opinion. They believed that the convening and convening of the second extraordinary shareholders meeting of the company in 2014, the convener The qualifications of the shareholders or proxies and other personnel attending the meeting, the deliberation and voting procedures of the shareholders' meeting are in compliance with the laws, regulations, normative documents and the Articles of Association of the Company Law and the Rules of the General Meeting of Shareholders. It is stipulated that the voting results are legal and valid.

Fourth, the documents for reference

1. Resolution of the second extraordinary shareholders meeting of Jilin Zixin Pharmaceutical Co., Ltd. in 2014;

2. The Legal Opinion on the Second Extraordinary General Meeting of 2014 held by Jilin Zixin Pharmaceutical Co., Ltd. issued by Dalian Branch of Beijing Law Firm.

Special announcement.

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

April 12, 2014